Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells

By              

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1879-1886

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen-Induced Increases in Cytoplasmic Free Ca^2+ Levels in Human Breast Cancer Cells

By Chang H-T.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 2, 2002-01 ,pp. : 125-131

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen Added to Adjuvant Chemotherapy in Premenopausal Women with Early Breast Cancer: is it Standard Practice or Still a Subject for Study?

By Bramwell V.H.C.   Pritchard K.I.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1625-1627

Elsevier

Access to resources Recommend Favorite

Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen

By Fung M.F.K.   Reid A.   Faught W.   Le T.   Chenier C.   Verma S.   Brydon E.   Fung K.F.K.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 154-159

Elsevier

Access to resources Recommend Favorite